Exhibit 99.1
MEDCATH CORPORATION
SUPPLEMENTAL FINANCIAL DISCLOSURE — RECONCILIATION OF GAAP FINANCIAL MEASURES
TO NON-GAAP FINANCIAL MEASURES
(Unaudited)
The following table reconciles the (loss) income from continuing operations, net of taxes attributable to MedCath Corporation’s common
stockholders as derived directly from MedCath Corporation’s consolidated financial statements to Adjusted EBITDA for the
three and six months ended March 31, 2010 and 2009.
| | | | | | | | | | | | | | | | |
| | Three Months Ended March 31, | | | Six Months Ended March 31, | |
| | 2010 | | | 2009 | | | 2010 | | | 2009 | |
| | (in thousands) | | | (in thousands) | |
|
(Loss) income from continuing operations, net of taxes | | $ | (11,999 | ) | | $ | 4,220 | | | $ | (15,091 | ) | | $ | 1,685 | |
Add: | | | | | | | | | | | | | | | | |
Income tax (benefit) expense | | | (7,386 | ) | | | 2,610 | | | | (9,287 | ) | | | 1,115 | |
Net income attributable to noncontrolling interest | | | 2,151 | | | | 3,767 | | | | 2,856 | | | | 5,816 | |
Equity in net earnings of unconsolidated affiliates | | | (3,206 | ) | | | (2,714 | ) | | | (4,722 | ) | | | (4,779 | ) |
Interest and other income | | | (23 | ) | | | (73 | ) | | | (93 | ) | | | (172 | ) |
Loss on note receivable | | | 1,507 | | | | — | | | | 1,507 | | | | — | |
Loss on early extinguishment of debt | | | — | | | | (259 | ) | | | — | | | | 6,702 | |
Interest expense | | | 1,149 | | | | 581 | | | | 2,207 | | | | 2,678 | |
(Gain) loss on disposal of property, equipment and other assets | | | (76 | ) | | | 108 | | | | 19 | | | | 181 | |
Impairment of property and equipment | | | 19,948 | | | | — | | | | 19,948 | | | | — | |
Impairment of equity method investment | | | 114 | | | | — | | | | 114 | | | | — | |
Amortization | | | 8 | | | | 8 | | | | 16 | | | | 16 | |
Depreciation | | | 7,768 | | | | 6,217 | | | | 15,418 | | | | 12,713 | |
Pre-opening expenses | | | — | | | | 380 | | | | 866 | | | | 587 | |
Share-based compensation expense | | | 1,217 | | | | 839 | | | | 1,826 | | | | 1,837 | |
| | | | | | | | | | | | |
Adjusted EBITDA | | $ | 11,172 | | | $ | 15,684 | | | $ | 15,584 | | | $ | 28,379 | |
| | | | | | | | | | | | |
The following table reconciles MedCath Corporation’s diluted (loss) earnings per share from continuing operations attributable to MedCath Corporations common stockholders as derived directly from MedCath’s consolidated financial statements to Adjusted diluted earnings (loss) per share from continuing operations for the three and six months ended March 31, 2010 and 2009.
| | | | | | | | | | | | | | | | |
| | Three Months Ended March 31, | | | Six Months Ended March 31, | |
| | 2010 | | | 2009 | | | 2010 | | | 2009 | |
|
Diluted (loss) earnings per share | | $ | (0.61 | ) | | $ | 0.21 | | | $ | (0.76 | ) | | $ | 0.09 | |
Add: | | | | | | | | | | | | | | | | |
Loss on early extinguishment of debt | | | — | | | | — | | | | — | | | | 0.22 | |
Impairments of property, equipment, and equity method investment | | | 0.62 | | | | — | | | | 0.62 | | | | — | |
Loss on note receivable | | | 0.05 | | | | — | | | | 0.05 | | | | — | |
Share-based compensation expense | | | 0.04 | | | | 0.03 | | | | 0.06 | | | | 0.04 | |
Pre-opening expense | | | — | | | | 0.01 | | | | 0.02 | | | | 0.02 | |
| | | | | | | | | | | | |
Adjusted diluted earnings (loss) per share | | $ | 0.10 | | | $ | 0.25 | | | $ | (0.01 | ) | | $ | 0.37 | |
| | | | | | | | | | | | |